Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Feb 13;33(7):2784–2793. doi: 10.1523/JNEUROSCI.4116-12.2013

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2013 the authors 0270-6474/13/332784-10$15.00/0

PMC Copyright notice

Figure 6. — CLSM images close to the trigeminal ganglion following the injection of the anterograde BDA tracer into the abducens nucleus (cat 4). Images from a single optical section show the ophthalmic (NV1) and maxillary (NV2) nerve divisions, as well as the abducens nerve (NVI). A few cell bodies belonging to the maxillary division of the trigeminal ganglion are also visible (arrow) A–C, Staining with anti-neurofilament (red) and BDA tracer visualization with streptavidin (green) A, All the components are stained by the antibody to neurofilament protein. B, Only the abducens nerve is tracer-positive. C, Overlay of A and B showing that neurofilament/tracer-positive axons in yellow mixed color are limited to the abducens nerve. Scale bar, 100 μm.